Ling Ma
Impact in
-
- Cancer-related Molecular Pathways
- PARP inhibition in cancer therapy
-
- Advanced Breast Cancer Therapies
- Photodynamic Therapy Research Studies
Papers in
-
- Advanced Breast Cancer Therapies 4
- Oncology 7
- PARP inhibition in cancer therapy 4
- Cancer Treatment and Pharmacology 2
- Co-authors
- Živilė Lukšiené (1 shared paper)Kristian Berg (1 shared paper)Johan Moan (1 shared paper)Sharon Wilks (5 shared papers)Michael A. Danso (5 shared papers)Željko Vojnović (4 shared papers)Gail S. Wright (4 shared papers)Timothy Pluard (4 shared papers)
- Journals
- Journal of Clinical Oncology (4 papers)Clinical Cancer Research (1 paper)Medicine (1 paper)Bioconjugate Chemistry (1 paper)Annals of Oncology (1 paper)
- Partner nations
- United StatesUnited KingdomSerbia
In The Last Decade
Ling Ma
16 papers receiving 393 citations
Peers
Comparison fields: 5 of 56
- Oncology 145
- Pulmonary and Respiratory Medicine 164
- Reproductive Medicine 36
- Obstetrics and Gynecology 23
- Cancer Research 39
Countries citing papers authored by Ling Ma
This map shows the geographic impact of Ling Ma's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ling Ma with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ling Ma more than expected).
Fields of papers citing papers by Ling Ma
This network shows the impact of papers produced by Ling Ma. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ling Ma. The network helps show where Ling Ma may publish in the future.
Co-authors
The 25 scholars most cited alongside Ling Ma, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2019 | 90 | |
| 2 | 2016 | 65 | |
| 3 | 1995 | 47 | |
| 4 | 2019 | 34 | |
| 5 | 2021 | 30 | |
| 6 | 2021 | 26 | |
| 7 | 2016 | 21 | |
| 8 | 2022 | 17 | |
| 9 | 2020 | 14 | |
| 10 | 2016 | 13 | |
| 11 | 2022 | 12 | |
| 12 | 2014 | 12 | |
| 13 | 2021 | 6 | |
| 14 | 2021 | 5 | |
| 15 | 2023 | 4 | |
| 16 | 2021 | 3 | |
| 17 | 2019 | 0 |
About Ling Ma
Ling Ma is a scholar working on Pulmonary and Respiratory Medicine, Oncology, Molecular Biology, Reproductive Medicine and Biomedical Engineering, having authored 17 papers that have together received 399 indexed citations. Recurring topics across this work include PARP inhibition in cancer therapy (4 papers), Advanced Breast Cancer Therapies (4 papers), Ovarian cancer diagnosis and treatment (3 papers), Endometrial and Cervical Cancer Treatments (2 papers), Cancer Treatment and Pharmacology (2 papers), Photoacoustic and Ultrasonic Imaging (2 papers), CRISPR and Genetic Engineering (2 papers) and Nanoplatforms for cancer theranostics (2 papers). The work is most often cited by research in Oncology (145 citations), Pulmonary and Respiratory Medicine (164 citations), Reproductive Medicine (36 citations), Obstetrics and Gynecology (23 citations) and Cancer Research (39 citations). Ling Ma has collaborated with scholars based in United States, United Kingdom and Serbia. Frequent co-authors include Živilė Lukšiené, Kristian Berg, Johan Moan, Sharon Wilks, Michael A. Danso, Željko Vojnović, Gail S. Wright, Timothy Pluard, Anu Thummala and Dušan Milenković. Their work appears in journals such as Journal of Clinical Oncology, Clinical Cancer Research, Medicine, Bioconjugate Chemistry and Annals of Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.